Gianna Ragagnin

Title: Gianna Ragagnin: Innovator in CNS Disorder Treatments

Introduction

Gianna Ragagnin is a notable inventor specializing in the development of pharmaceutical compositions for the treatment of central nervous system (CNS) disorders. Her innovative work focuses on compounds that modulate brain excitability, offering potential solutions for various neurological conditions.

Latest Patents

Gianna Ragagnin holds several patents, including:

1. **3.alpha.-Ethynyl, 3.beta.-Hydroxy-5.alpha.-Pregnan-20-Oxime For Use In The Treatment Of CNS Disorders** - This invention relates to compounds that are useful as modulators of the mammal brain excitability via the gamma-aminobutyric acid receptor-chloride ionophore (GABA A-R) complex. These compounds are aimed at treating disorders such as hepatic encephalopathy, Down's syndrome, and Alzheimer's disease.

2. **The Use Of Pregnane And Androstane Steroids For The Manufacture Of A Pharmaceutical Composition For The Treatment Of CNS Disorders** - This patent discloses steroid compounds with increased resistance against metabolism and enhanced water solubility. These substances are suitable for the manufacture of pharmaceuticals aimed at treating steroid-related or steroid-induced CNS disorders.

Career Highlights

Throughout her career, Gianna has worked with companies such as Umecrine AB and Umecrine Cognition AB. Her contributions to the field of CNS disorders have been significant, showcasing her dedication to advancing medical treatments.

Collaborations

Gianna has collaborated with professionals in her field, including her coworker Torbjorn Backstrom. These partnerships have facilitated the development of her innovative ideas and patents.

Conclusion

Gianna Ragagnin is a pioneering inventor whose work in CNS disorder treatments has the potential to make a significant impact on healthcare. Her innovative patents and collaborations highlight her commitment to advancing medical science.